Steven P. Coen - Sep 11, 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Accounting Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Sep 11, 2024
Transactions value $
-$1,950
Form type
4
Date filed
9/16/2024, 04:28 PM
Previous filing
Aug 6, 2024
Next filing
Oct 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +587 +11.33% 5.77K Sep 11, 2024 Direct F1, F2
transaction DNA Class A Common Stock Options Exercise +156 +2.7% 5.93K Sep 11, 2024 Direct F1, F2
transaction DNA Class A Common Stock Sale -$1.95K -316 -5.33% $6.17* 5.61K Sep 12, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -587 -3.03% 18.8K Sep 11, 2024 Class A Common Stock 587 Direct F1, F2, F4
transaction DNA Restricted Stock Units Options Exercise -156 -2.32% 6.56K Sep 11, 2024 Class A Common Stock 156 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024.
F3 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F4 The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
F5 The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Remarks:

Chief Accounting Officer